open access

Vol 6, No 1 (2001)
Untitled
Published online: 2001-01-01
Submitted:
Get Citation

45. Impact of Hb level during postoperative radiotherapy of patients with larynx cancer

P. Milecki, S. Nawrocki, G. Stryczyńska, A. Kruk-Zagajewska, D. Fundowicz
DOI: 10.1016/S1507-1367(01)70415-4
·
Rep Pract Oncol Radiother 2001;6(1):47-48.

open access

Vol 6, No 1 (2001)
Untitled
Published online: 2001-01-01
Submitted:

Abstract

Aim

Assessment the influence of low level of Hgb on the locoregional outcome of postoperative radiotherapy patients with advanced cancer of larynx.

Material and methods

An retrospective analysis of two hundred fifty four patients with larynx carcinoma with stage III or IV squamous cell carcinoma of larynx who were treated between January 1993 and December 1996 was performed. Postoperative radiotherapy was performed in coventional way to total dose of 60 Gy, 5 times a week. Of 254 patients, 86 patients (34%) were considered to have a low level of hemoglobin (below 13 g/dl) prior the beginning of radiotherapy and 56 patients (22%) at the end of treatment. We have noted also 38 patients (15%) of 254 patients, with deacresing hemoglobin level during treatment higher than 1 g/dl.

Results

No impact on outcome of treatment was observed in the group of patients with low level of Hgb before irradiation. Inrease of locoregional failure of postoperative radiotherapy was noted in group of patients with Hgb level at the end of irradiation below 13 g/dl (p = 0,004) and also in group of patients with decreasing of Hgb level during treatment (p = 0,038).

Conclusions

Low Hgb levels at the end of postoperative irradiation and decreasing during irradiation were associated with a statistically significant an increase in locoregional failure of patients with advanced carcinoma of larynx.

Abstract

Aim

Assessment the influence of low level of Hgb on the locoregional outcome of postoperative radiotherapy patients with advanced cancer of larynx.

Material and methods

An retrospective analysis of two hundred fifty four patients with larynx carcinoma with stage III or IV squamous cell carcinoma of larynx who were treated between January 1993 and December 1996 was performed. Postoperative radiotherapy was performed in coventional way to total dose of 60 Gy, 5 times a week. Of 254 patients, 86 patients (34%) were considered to have a low level of hemoglobin (below 13 g/dl) prior the beginning of radiotherapy and 56 patients (22%) at the end of treatment. We have noted also 38 patients (15%) of 254 patients, with deacresing hemoglobin level during treatment higher than 1 g/dl.

Results

No impact on outcome of treatment was observed in the group of patients with low level of Hgb before irradiation. Inrease of locoregional failure of postoperative radiotherapy was noted in group of patients with Hgb level at the end of irradiation below 13 g/dl (p = 0,004) and also in group of patients with decreasing of Hgb level during treatment (p = 0,038).

Conclusions

Low Hgb levels at the end of postoperative irradiation and decreasing during irradiation were associated with a statistically significant an increase in locoregional failure of patients with advanced carcinoma of larynx.

Get Citation
About this article
Title

45. Impact of Hb level during postoperative radiotherapy of patients with larynx cancer

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 6, No 1 (2001)

Pages

47-48

Published online

2001-01-01

DOI

10.1016/S1507-1367(01)70415-4

Bibliographic record

Rep Pract Oncol Radiother 2001;6(1):47-48.

Authors

P. Milecki
S. Nawrocki
G. Stryczyńska
A. Kruk-Zagajewska
D. Fundowicz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl